Cerity Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8M | Buy |
92,933
+16,618
| +22% | +$1.46M | 0.01% | 869 |
|
|
2026
Q1 | $6.9M | Buy |
76,315
+12,826
| +20% | +$1.18M | 0.01% | 868 |
|
|
2025
Q4 | $5.71M | Sell |
63,489
-566
| -0.9% | -$53.7K | 0.01% | 862 |
|
|
2025
Q3 | $6.31M | Sell |
64,055
-12,730
| -17% | -$1.26M | 0.01% | 766 |
|
|
2025
Q2 | $7M | Buy |
76,785
+37,116
| +94% | +$3.59M | 0.01% | 673 |
|
|
2025
Q1 | $4.49M | Sell |
39,669
-3,282
| -8% | -$351K | 0.01% | 772 |
|
|
2024
Q4 | $4.59M | Buy |
42,951
+2,644
| +7% | +$284K | 0.01% | 750 |
|
|
2024
Q3 | $4.35M | Buy |
40,307
+8,999
| +29% | +$982K | 0.01% | 751 |
|
|
2024
Q2 | $3.4M | Sell |
31,308
-9,422
| -23% | -$1.11M | 0.01% | 723 |
|
|
2024
Q1 | $5.32M | Buy |
40,730
+23,386
| +135% | +$2.92M | 0.01% | 634 |
|
|
2023
Q4 | $2.11M | Buy |
17,344
+5,024
| +41% | +$561K | 0.01% | 757 |
|
|
2023
Q3 | $1.38M | Sell |
12,320
-16,232
| -57% | -$2.06M | 0.01% | 671 |
|
|
2023
Q2 | $4.16M | Buy |
28,552
+170
| +0.6% | +$23.1K | 0.02% | 541 |
|
|
2023
Q1 | $4.44M | Buy |
28,382
+3,048
| +12% | +$383K | 0.01% | 519 |
|
|
2022
Q4 | $3.23M | Sell |
25,334
-451
| -2% | -$52.3K | 0.02% | 446 |
|
|
2022
Q3 | $2.69M | Sell |
25,785
-1,470
| -5% | -$161K | 0.03% | 329 |
|
|
2022
Q2 | $2.86M | Sell |
27,255
-7,736
| -22% | -$918K | 0.03% | 336 |
|
|
2022
Q1 | $4.48M | Buy |
34,991
+12,385
| +55% | +$1.49M | 0.07% | 208 |
|
|
2021
Q4 | $2.79M | Sell |
22,606
-12,503
| -36% | -$1.64M | 0.04% | 271 |
|
|
2021
Q3 | $4.99M | Buy |
35,109
+214
| +0.6% | +$31.5K | 0.11% | 157 |
|
|
2021
Q2 | $5.45M | Buy |
34,895
+3,099
| +10% | +$502K | 0.12% | 153 |
|
|
2021
Q1 | $4.94M | Buy |
31,796
+18,857
| +146% | +$2.92M | 0.12% | 150 |
|
|
2020
Q4 | $1.94M | Buy |
12,939
+244
| +2% | +$34.5K | 0.06% | 219 |
|
|
2020
Q3 | $1.68M | Buy |
12,695
+2,057
| +19% | +$269K | 0.07% | 189 |
|
|
2020
Q2 | $1.23M | Sell |
10,638
-11
| -0.1% | -$1.27K | 0.07% | 178 |
|
|
2020
Q1 | $1.04M | Sell |
10,649
-306
| -3% | -$40.1K | 0.07% | 196 |
|
|
2019
Q4 | $1.59M | Sell |
10,955
-808
| -7% | -$112K | 0.08% | 183 |
|
|
2019
Q3 | $1.57M | Buy |
11,763
+157
| +1% | +$20.3K | 0.09% | 194 |
|
|
2019
Q2 | $1.33M | Sell |
11,606
-337
| -3% | -$39.5K | 0.08% | 200 |
|
|
2019
Q1 | $1.48M | Sell |
11,943
-206
| -2% | -$23.4K | 0.1% | 192 |
|
|
2018
Q4 | $1.22M | Buy |
12,149
+293
| +2% | +$33K | 0.08% | 203 |
|
|
2018
Q3 | $1.51M | Sell |
11,856
-1,782
| -13% | -$212K | 0.1% | 194 |
|
|
2018
Q2 | $1.48M | Buy |
13,638
+3,091
| +29% | +$336K | 0.11% | 198 |
|
|
2018
Q1 | $1.12M | Sell |
10,547
-1,770
| -14% | -$206K | 0.09% | 218 |
|
|
2017
Q4 | $1.44M | Buy |
12,317
+499
| +4% | +$56.4K | 0.1% | 193 |
|
|
2017
Q3 | $1.34M | Buy |
11,818
+1,141
| +11% | +$132K | 0.1% | 198 |
|
|
2017
Q2 | $1.33M | Buy |
10,677
+232
| +2% | +$27.5K | 0.11% | 148 |
|
|
2017
Q1 | $1.24M | Buy |
+10,445
| New | +$1.18M | 0.1% | 165 |
|
Other funds holding ZBH
Cerity Partners's ZBH Position: Q2 2026 in Review
Cerity Partners increased its Zimmer Biomet (ZBH) stake by 22% in Q2 2026, buying an estimated $1.46M and bringing the position to 92,933 shares worth $8M. The position accounts for 0.01% of the portfolio, ranked #869.
Cerity Partners first reported a position in ZBH in Q1 2017 and has held it in 38 quarters since. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Cerity Partners held 92,933 shares of Zimmer Biomet worth $8M as of Q2 2026.
- Cerity Partners bought 16,618 Zimmer Biomet shares in Q2 2026, an estimated $1.46M.
- Zimmer Biomet made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #869 holding.
- Cerity Partners first reported a position in Zimmer Biomet in Q1 2017 and has held it in 38 quarters since.
- 853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.